Accepting Immunotherapy After Multiline Treatment Failure: An Exploration of the Anxiety and Depression in Patients with Advanced Cancer Experience

MLA

Xie Q, et al. “Accepting Immunotherapy After Multiline Treatment Failure: An Exploration of the Anxiety and Depression in Patients with Advanced Cancer Experience.” Patient Preference and Adherence, vol. ume 16, Jan. 2022, pp. 1–9. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsdoj&AN=edsdoj.096c6a64fc9645a1902d1dae85c3fa47&authtype=sso&custid=ns315887.

APA

Xie Q, Sun C, Fei Z, & Yang X. (2022). Accepting Immunotherapy After Multiline Treatment Failure: An Exploration of the Anxiety and Depression in Patients with Advanced Cancer Experience. Patient Preference and Adherence, ume 16, 1–9.

Chicago

Xie Q, Sun C, Fei Z, and Yang X. 2022. “Accepting Immunotherapy After Multiline Treatment Failure: An Exploration of the Anxiety and Depression in Patients with Advanced Cancer Experience.” Patient Preference and Adherence ume 16 (January): 1–9. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsdoj&AN=edsdoj.096c6a64fc9645a1902d1dae85c3fa47&authtype=sso&custid=ns315887.